<p>Latently infected primary CD4 T cells prepared from three independent healthy donors were treated with the indicated compounds continuously for 48 hours. EC<sub>50</sub> and CC<sub>50</sub> values were determined from each dose-dependent response using a multi-parameter algorithm. Data are mean ± SD from three independent experiments performed in quadruplicate.</p
<p>Cell viability and luciferase activities were measured in separate plates of MCF7-AREc32 cells ex...
(A) Uninfected human primary CD4+ T cells were stimulated for 24 hours with DMSO, kansui, or PC1 at ...
BACKGROUND. The histone deacetylase (HDAC) inhibitor vorinostat (VOR) can increase HIV RNA expressio...
<p>Primary CD4 T cells latently infected in vitro with reporter HIV were established as previously d...
<p>Resting CD4 T cells isolated from cART-suppressed HIV-infected patients were pulse-treated with R...
<p>A. HIV-1 outgrowth from latently infected CD4+ T cells following overnight exposure to 15 µM BRD3...
Abstract Recently, there is considerable interest in the field of anti-HIV therapy to identify and d...
Objectives: To compare the potency, toxicity and mechanism of action of multiple histone deacetylase...
OBJECTIVE: We aimed to compare the potential for inducing HIV production and the effect on T-cell ac...
Objectives: The latent reservoir for HIV-1 in resting memory CD4+ T cells is a major barrier to erad...
<p><b>A, B</b>. PBMC or CTL clones from chronically HIV-infected ARV-treated subjects (OM265 and OM2...
<p>PBMC from 11 chronically HIV-infected subjects on suppressive ARV therapy were labeled with CFSE ...
<p><b>A–C</b>. PBMC were treated with HDACi drugs at the indicated concentrations for either 4 or 21...
<p>(A) The fraction of cells reactivated, <i>f</i><sub><i>on</i></sub>, as a function of the fold-in...
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for...
<p>Cell viability and luciferase activities were measured in separate plates of MCF7-AREc32 cells ex...
(A) Uninfected human primary CD4+ T cells were stimulated for 24 hours with DMSO, kansui, or PC1 at ...
BACKGROUND. The histone deacetylase (HDAC) inhibitor vorinostat (VOR) can increase HIV RNA expressio...
<p>Primary CD4 T cells latently infected in vitro with reporter HIV were established as previously d...
<p>Resting CD4 T cells isolated from cART-suppressed HIV-infected patients were pulse-treated with R...
<p>A. HIV-1 outgrowth from latently infected CD4+ T cells following overnight exposure to 15 µM BRD3...
Abstract Recently, there is considerable interest in the field of anti-HIV therapy to identify and d...
Objectives: To compare the potency, toxicity and mechanism of action of multiple histone deacetylase...
OBJECTIVE: We aimed to compare the potential for inducing HIV production and the effect on T-cell ac...
Objectives: The latent reservoir for HIV-1 in resting memory CD4+ T cells is a major barrier to erad...
<p><b>A, B</b>. PBMC or CTL clones from chronically HIV-infected ARV-treated subjects (OM265 and OM2...
<p>PBMC from 11 chronically HIV-infected subjects on suppressive ARV therapy were labeled with CFSE ...
<p><b>A–C</b>. PBMC were treated with HDACi drugs at the indicated concentrations for either 4 or 21...
<p>(A) The fraction of cells reactivated, <i>f</i><sub><i>on</i></sub>, as a function of the fold-in...
Selective histone deacetylase (HDAC) inhibitors have emerged as a potential anti-latency therapy for...
<p>Cell viability and luciferase activities were measured in separate plates of MCF7-AREc32 cells ex...
(A) Uninfected human primary CD4+ T cells were stimulated for 24 hours with DMSO, kansui, or PC1 at ...
BACKGROUND. The histone deacetylase (HDAC) inhibitor vorinostat (VOR) can increase HIV RNA expressio...